1. Home
  2. HCWB vs QH Comparison

HCWB vs QH Comparison

Compare HCWB & QH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HCWB

HCW Biologics Inc.

HOLD

Current Price

$2.66

Market Cap

14.8M

Sector

Health Care

ML Signal

HOLD

QH

Quhuo Limited American Depository Shares

SELL

Current Price

$5.63

Market Cap

14.8M

ML Signal

SELL

Company Overview

Basic Information
Metric
HCWB
QH
Founded
2018
2012
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
14.8M
14.8M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
HCWB
QH
Price
$2.66
$5.63
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$35.00
N/A
AVG Volume (30 Days)
93.4K
41.9K
Earning Date
05-15-2026
04-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.37
N/A
Revenue
$4,099,750.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.78
$2.86
Revenue Growth
N/A
N/A
52 Week Low
$0.25
$0.06
52 Week High
$7.35
$12.81

Technical Indicators

Market Signals
Indicator
HCWB
QH
Relative Strength Index (RSI) 43.29 47.26
Support Level $0.37 $0.46
Resistance Level $3.89 $7.29
Average True Range (ATR) 0.35 0.81
MACD -0.26 -0.27
Stochastic Oscillator 3.05 46.56

Price Performance

Historical Comparison
HCWB
QH

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

About QH Quhuo Limited American Depository Shares

Quhuo Ltd is a gig economy platform focusing on local life services in China. It provide tech-enabled, end-to-end operational solutions to consumer service businesses, including on-demand delivery solutions, mobility service solutions, housekeeping and accommodation solutions, and other services. Its three operating segments, include (i) on-demand delivery solutions, (ii) mobility service solutions, and (iii) housekeeping and accommodation solutions and other services. It generates maximum of its revenue from the on-demand delivery solutions segment.

Share on Social Networks: